Vera Therapeutics VERA Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3.2×+0.7×

Travere Therapeutics, Inc.TVTX

3.1×+1.1×

Aurinia PharmaceuticalsAUPH

5.4×+0.2×

Climb Bio, Inc.CLYM

27.9×+13.6×

Jade BiosciencesJBIO

14.3×-17.7×

Viridian Therapeutics, Inc.VRDN

16.9×+5.9×

FAQ

What is Vera Therapeutics's current ratio?

Vera Therapeutics (VERA) reported current ratio of 13.6× in Q1 2026.

How has Vera Therapeutics's current ratio changed year-over-year?

Vera Therapeutics's current ratio decreased by 50.7% year-over-year, from 27.7× to 13.6×.

What is the long-term trend for Vera Therapeutics's current ratio?

Over 5 years (2020 to 2025), Vera Therapeutics's current ratio has grown at a -9.6% compound annual growth rate (CAGR), from 22.6× to 13.6×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.